Non Applicability of Filing Statement of Deviation/Variation in Utilization of Funds for Quarter and Year Ended 31st March, 2025
Announcement Pursuant To Regulation 32 Of SEBI (LODR) Regulations, 2015 - Non Applicability Of Filing Statement Of Deviation / Variation In Utilization Of Funds For Quarter And Year Ended 31St March, 2025
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Welcure Drugs and Pharmaceuticals Ltd. on 6ix
Earlier from Welcure Drugs and Pharmaceuticals
- Announcement under Regulation 30 (LODR)-Change in Management
- Audited Standalone Financial Results And Audited Standalone Financial Statements Along With Auditor'S Report Of The Company For The Quarter And Year Ended March 31, 2025
- Board Meeting Outcome for Outcome Of Board Meeting
- Welcure Drugs And Pharmaceuticals Ltd. Press Release May 20 2025
- Board Meeting Intimation for For Consideration And Approval Of The Audited Financial ResultsFor The Quarter/Year Ended 31St March, 2025 Alongwith Statement Of Assets And Liabilities And Cash FlowStatement For The Year Ended 31St March, 2025
Later from Welcure Drugs and Pharmaceuticals
- Compliances-Reg.24(A)-Annual Secretarial Compliance
- Welcure Drugs And Pharmaceuticals Ltd. Press Release May 29 2025
- Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Jun 17 2025
- Intimation Under Regulation 30 - Rs. 517 Crore Global Sourcing Mandate
Follow Welcure Drugs and Pharmaceuticals into a list and get an email when it puts out news.
Follow Welcure Drugs and Pharmaceuticals